Get started
Hansa Medical ABHansa Medical ABHansa Medical AB

Hansa Medical AB

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

HNSBF chart


Full chart

HNSBF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪354.21 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.91 USD
Net income (FY)
‪−72.65 M‬ USD
Revenue (FY)
‪15.42 M‬ USD
Shares float
‪82.14 M‬
Beta (1Y)
0.28

Employees


Employees (FY)
135
Change (1Y)
−33 −19.64%
Revenue / Employee (1Y)
‪114.21 K‬ USD
Net income / Employee (1Y)
‪−538.16 K‬ USD

About Hansa Biopharma AB


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Renée Julie Elisabet Aguiar-Lucander
Website
hansabiopharma.com
Headquarters
Lund
Founded
2007
ISIN
SE0002148817
FIGI
BBG0076T0YC6
Hansa Biopharma AB focuses on novel immunomodulatory enzymes, which treat rare immunoglobulin G-mediated autoimmune conditions, transplant rejection and cancer. Its pipeline includes IdeS, HBP-assay, EnzE, and NiceR. The company was founded by Lars Björck and Bo Krister Håkansson in 2001 and is headquartered in Lund, Sweden.

Check out other big names from the same industry as HNSBF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HNSBF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HNSBF is 4.58 USD — it has increased by 52.67% in the past 24 hours. Watch Hansa Medical AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hansa Medical AB stocks are traded under the ticker HNSBF.
HNSBF stock has risen by 67.77% compared to the previous week, the month change is a 67.15% rise, over the last year Hansa Medical AB has showed a 40.71% increase.
We've gathered analysts' opinions on Hansa Medical AB future price: according to them, HNSBF price has a max estimate of 15.14 USD and a min estimate of 3.92 USD. Watch HNSBF chart and read a more detailed Hansa Medical AB stock forecast: see what analysts think of Hansa Medical AB and suggest that you do with its stocks.
HNSBF reached its all-time high on Oct 9, 2018 with the price of 35.91 USD, and its all-time low was 2.26 USD and was reached on Dec 19, 2023. View more price dynamics on HNSBF chart.
See other stocks reaching their highest and lowest prices.
HNSBF stock is 34.50% volatile and has beta coefficient of 0.28. Track Hansa Medical AB stock price on the chart and check out the list of the most volatile stocks — is Hansa Medical AB there?
Today Hansa Medical AB has the market capitalization of ‪354.21 M‬, it has increased by 19.14% over the last week.
Yes, you can track Hansa Medical AB financials in yearly and quarterly reports right on TradingView.
Hansa Medical AB is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
HNSBF earnings for the last quarter are −0.27 USD per share, whereas the estimation was −0.17 USD resulting in a −52.41% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Hansa Medical AB earnings.
Hansa Medical AB revenue for the last quarter amounts to ‪5.17 M‬ USD, despite the estimated figure of ‪6.21 M‬ USD. In the next quarter, revenue is expected to reach ‪5.73 M‬ USD.
HNSBF net income for the last quarter is ‪−18.82 M‬ USD, while the quarter before that showed ‪−3.68 M‬ USD of net income which accounts for −411.67% change. Track more Hansa Medical AB financial stats to get the full picture.
No, HNSBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 2, 2025, the company has 135 employees. See our rating of the largest employees — is Hansa Medical AB on this list?
Like other stocks, HNSBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hansa Medical AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hansa Medical AB technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hansa Medical AB stock shows the neutral signal. See more of Hansa Medical AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.